Share on LinkedInShare on LinkedIn

ARTICLE · 12 JULY 2016

PTO Cancer Immunotherapy Fast Track

Sheppard
Sheppard
Contributor
Sheppard

Sheppard

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more...

View firm profile
Explore more from Sheppard

In response to President Obama's National Cancer Moonshot initiative to eliminate cancer, the USPTO has launched the "Cancer Immunotherapy Pilot Program."

United StatesIntellectual Property

In response to President Obama's National Cancer Moonshot initiative to eliminate cancer, the USPTO has launched the "Cancer Immunotherapy Pilot Program." The Pilot Program provides an accelerated review for applications related to cancer immunotherapy and is set to launch in July 2016. According to the USPTO, this initiative:

  • aims to cut the time it takes to review patent applications in cancer therapy in half (final decisions in 12 months or less);
  • is open to any applicant, including early stage bio-tech companies, universities, and large pharmaceutical firms;
  • is open to entities who may have products already in FDA-approved clinical trials, allowing them to opt in, even if they have a patent application already filed; and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from